Roche pushes back Spark merger deadline as U.S., U.K. antitrust reviews drag on

8th July 2019 Uncategorised 0

Roche and Spark Therapeutics’ road to a $4.3 billion merger has been a rocky one, with various delays pushing the long-gestating agreement back four times. Now, in order to get all its regulatory ducks in a row, Roche is moving its own deal-close deadline back as well.

More: Roche pushes back Spark merger deadline as U.S., U.K. antitrust reviews drag on
Source: fierce